No. 25-348
AstraZeneca Pharmaceuticals LP, et al. v. Robert F. Kennedy, Secretary of Health and Human Services, et al.
Tags: drug-price-negotiation due-process government-pricing inflation-reduction-act medicare-transactions pharmaceutical-manufacturers
Latest Conference:
2026-01-23
Question Presented (from Petition)
Whether the IRA implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause.
Question Presented (AI Summary)
Whether the IRA implicates an interest of pharmaceutical manufacturers that is protected by the Due Process Clause
Docket Entries
2026-01-22
Rescheduled.
2026-01-07
Reply of petitioners AstraZeneca Pharmaceuticals LP, et al. filed. (Distributed)
2026-01-07
Reply of AstraZeneca Pharmaceuticals LP, et al. submitted.
2026-01-07
DISTRIBUTED for Conference of 1/23/2026.
2026-01-02
Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.
2026-01-02
Waiver of AstraZeneca Pharmaceuticals LP, et al. of the 14-day waiting period submitted.
2026-01-02
Brief of respondents Secretary of Health and Human Services, Robert F. Kennedy, et al. in opposition filed.
2025-12-19
Motion to extend the time to file a response is granted and the time is further extended to and including January 2, 2026.
2025-12-18
Motion of Secretary of Health and Human Services, Robert F. Kennedy,, et al. for an extension of time submitted.
2025-12-18
Motion to extend the time to file a response from December 24, 2025 to January 2, 2026, submitted to The Clerk.
2025-11-21
Motion to extend the time to file a response is granted and the time is further extended to and including December 24, 2025.
2025-11-20
Motion to extend the time to file a response from November 24, 2025 to December 24, 2025, submitted to The Clerk.
2025-11-20
Motion of Secretary of Health and Human Services, Robert F. Kennedy,, et al. for an extension of time submitted.
2025-09-29
Motion to extend the time to file a response is granted and the time is extended to and including November 24, 2025.
2025-09-26
Motion to extend the time to file a response from October 24, 2025 to November 24, 2025, submitted to The Clerk.
2025-09-26
Motion of Secretary of Health and Human Services, Robert F. Kennedy,, et al. for an extension of time submitted.
2025-09-19
Petition for a writ of certiorari filed. (Response due October 24, 2025)
2025-07-28
Application (25A115) granted by Justice Alito extending the time to file until September 20, 2025.
2025-07-24
Application (25A115) to extend the time to file a petition for a writ of certiorari from August 6, 2025 to September 20, 2025, submitted to Justice Alito.
Attorneys
AstraZeneca Pharmaceuticals LP, et al.
Allon Kedem — Arnold & Porter Kaye Scholer LLP, Petitioner
Secretary of Health and Human Services, Robert F. Kennedy,, et al.
D. John Sauer — Solicitor General, Respondent